Skip to main content
FTH
NASDAQ Life Sciences

FDA Grants Fast Track to Faeth's Piktor Combo in Endometrial Cancer

Tom Rudovsky · Reported by Reuters
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$32.44
Mkt Cap
$835.679M
52W Low
$7.21
52W High
$37.9
52W Position info
350% above low
Off High info
14% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

FTH has more than doubled off its 52-week low of $7.21 on elevated volume (2.0× avg).

Summary

The FDA granted Fast Track designation to Faeth's Piktor plus paclitaxel for biomarker-selected advanced endometrial cancer, a regulatory milestone that can speed development and review. The company also disclosed topline Phase 2 data in this indication is expected by year-end 2026, with interim Phase 1b/2 breast cancer data in 2027. This follows Q2 results showing a $16M net loss and $186.4M cash, and a recent insider sale of ~$3.6M by a 10% holder. Fast Track status validates the program's potential in a high-need cancer setting and sets a near-term data catalyst.

At the time of this announcement, FTH was trading at $32.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $835.7M. The 52-week trading range was $7.21 to $37.90. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

FTH - Latest Insights

FTH
Nov 09, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $22.50
Real-time Price: $10.25 info
Change: -$12.25 (-54%) info
Market Cap: $259.215M info
FTH
Nov 03, 2026, 8:10 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $19.20
Real-time Price: $10.25 info
Change: -$8.95 (-47%) info
Market Cap: $259.215M info
FTH
Nov 03, 2026, 7:30 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $19.23
Real-time Price: $10.25 info
Change: -$8.98 (-47%) info
Market Cap: $259.215M info
FTH
Aug 04, 2026, 7:40 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $30.00
Real-time Price: $10.25 info
Change: -$19.75 (-66%) info
Market Cap: $259.215M info
FTH
Aug 04, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $30.00
Real-time Price: $10.25 info
Change: -$19.75 (-66%) info
Market Cap: $259.215M info